Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01435811 · ClinicalTrials.gov registry record · Phase 1
Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)
A Phase 1 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT01435811 is a Phase 1 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 60 participants.
The verdict
NCT01435811, a Phase 1 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine a suitable dose of the human norovirus GII.4 challenge pool(CIN-1;031693) that induces illness in approximately 50% of susceptible subjects that would be useful for evaluation of vaccines and antivirals.
Interventions
- BIOLOGICAL Norovirus challenge pool (GII.4, CIN-1)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2011-08 |
| Est. Completion | 2012-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01435811
The ClinicalTrials.gov registry entry for NCT01435811 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Norovirus challenge pool (GII.4, CIN-1) is the first listed.
NCT01435811 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01435811 about?
NCT01435811 is a clinical study titled "Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)". The purpose of this study is to determine a suitable dose of the human norovirus GII.4 challenge pool(CIN-1;031693) that induces illness in approximately 50% of susceptible subjects that would be useful for evaluation of vaccines and antivirals.
What is the current status of trial NCT01435811?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2011-08. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01435811?
The interventions under investigation include: Norovirus challenge pool (GII.4, CIN-1) (BIOLOGICAL).
Who is sponsoring clinical trial NCT01435811?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.